Baxalta seeks FDA approvals for Adynovate for use in pediatric patients and surgical settings Feb. 29, 2016 No Comments
EMA grants orphan drug designation to TNT-009 for autoimmune hemolytic anemia Feb. 26, 2016 No Comments
Initiation of phase II study of fostamatinib in autoimmune hemolytic anemia Feb. 26, 2016 No Comments
First patient dosed in phase IIa study of factor VIIa-CTP for the treatment of hemophilia Feb. 24, 2016 No Comments
RSS